AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Endoglim M1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Endoglim M1 Tablet PR

Diabetease Duo tablets are a dual-action antidiabetic medication, combining two agents to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Always take Diabetease Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue this medication as prescribed, even if feeling well or experiencing controlled glucose levels. Premature discontinuation, without consulting your doctor, could lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication forms one part of a comprehensive diabetes management plan, which must also include dietary modifications, regular exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. The most common adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, trembling) and appropriate management strategies. Regular meals and readily available fast-acting glucose (sugary snacks or juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Consult your physician before using Diabetease Duo if pregnant or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be necessary.

Uses of Endoglim M1 Tablet PR

Managing Type 2 diabetes

Major Benefits of Endoglim M1 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Endoglim M1 Tablet PR with a meal.

Common Side effects of Endoglim M1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Endoglim M1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Ingest Endoglim M1 Tablet PR with a meal.

How Endoglim M1 Tablet PR works:

Endoglim M1 Tablet PR combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Endoglim M1 Tablet PR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim M1 Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Endoglim M1 Tablet PR are incompatible; the medication poses a potential risk of infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Endoglim M1 Tablet PR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Avoid using Endoglim M1 Tablet PR in patients exhibiting severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim M1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Endoglim M1 Tablet PR :

Should you forget a dose of Endoglim M1 Tablet PR, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim M1 Tablet PR

LabelValue
Addictive None.
Medication Classification Diabetes medication

FAQs on Endoglim M1 Tablet PR

Store this medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label or packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of Endoglim M1 Tablet PR use. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Endoglim M1 Tablet PR immediately and seek urgent medical attention.
Endoglim M1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood sugar control when used alongside a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. This dual therapy is unsuitable for type 1 DM.
Endoglim M1 Tablet PR administration may result in frequent side effects including hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, and cephalalgia. Rare, but potentially severe adverse reactions such as lactic acidosis may occur. Prolonged therapy may additionally cause vitamin B12 deficiency.
Prolonged Endoglim M1 Tablet PR use can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may manifest as anemia, neurological issues including paresthesia in the extremities, muscular weakness, urinary dysfunction, cognitive impairment, and gait disturbances. To mitigate these risks, supplemental Vitamin B12 intake, at least annually, is recommended by some studies.
Indeed, Endoglim M1 Tablet PR can induce hypoglycemia (low blood glucose). Characteristic symptoms of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is amplified by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Endoglim M1 Tablet PR and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Endoglim M1 Tablet PR
102
MRP 124
17% off